检索

期
标题
作者
卷 96, 编号 4 (2024)
The clinician's view on the advantages and contradictions of the new nomenclature of steatotic liver disease: A review
Pavlov C., Teplyuk D., Lazebnik L., Ametov A., Pashkova E., Sorokoletov S., Uspenskiy Y., Turkina S., Ponomarenko E., Maslakov A.
PDF
(Rus)
卷 94, 编号 12 (2022)
Lipid metabolism in non-alcoholic fatty liver disease in patients with different body weights in mid-mountain conditions
Toktogulova N., Sultanalieva R., Tuhvatshin R., Kaliev T.
PDF
(Rus)
卷 95, 编号 10 (2023)
Non-alcoholic fatty liver disease: aspects of management of a comorbid patient. A review
Demidova T., Ushanova F.
PDF
(Rus)
卷 94, 编号 2 (2022)
The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities
Maevskaya M., Kotovskaya Y., Ivashkin V., Tkacheva O., Troshina E., Shestakova M., Breder V., Geyvandova N., Doshchitsin V., Dudinskaya E., Ershova E., Kodzoeva K., Komshilova K., Korochanskaya N., Mayorov A., Mishina E., Nadinskaya M., Nikitin I., Pogosova N., Tarzimanova A., Shamkhalova M.
PDF
(Rus)
卷 94, 编号 10 (2022)
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: general approaches to the choice of therapy
Petunina N., Telnova M., Goncharova E., Martirosian N., Kuzina I.
PDF
(Rus)
卷 94, 编号 2 (2022)
The study of abdominal and parietal enteric microbiota in patients with non-alcoholic fatty liver disease
Vakhrushev Y., Lukashevich A., Lyapina M.
PDF
(Rus)
卷 94, 编号 12 (2022)
Subclinical markers of liver damage in patients with arterial hypertension and obesity
Sadulaeva I., Yushchuk E., Khalikova L., Krikunova O., Trofimenko O., Medvedeva E.
PDF
(Rus)
卷 94, 编号 8 (2022)
Modification of dietary patterns in patients with non-alcoholic steatohepatitis
Sasunova A., Goncharov A., Morozov S., Isakov V.
PDF
(Rus)
卷 95, 编号 8 (2023)
Use of a controlled attenuation parameter for the diagnosis of non-alcoholic fatty liver disease
Goncharov A., Sasunova A., Pilipenko V., Isakov V.
PDF
(Rus)
卷 95, 编号 8 (2023)
Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review
Golovina E., Vaizova O., Meleshko M., Samoilova I., Podchinenova D., Borozinets A., Matveeva M., Kudlay D.
PDF
(Rus)
卷 95, 编号 8 (2023)
Assessment of body mass index in patients with chronic hepatitis C who received an effective antiviral therapy
Dudina K., Belyy P., Maev I., Klimova E., Shutko S., Znoyko O., Yuschuk N.
PDF
(Rus)
卷 95, 编号 4 (2023)
Possibilities for the use of ursodeoxycholic acid in the treatment of patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease
Rasskazova M., Vorobyev S., Butova H.
PDF
(Rus)
卷 93, 编号 4 (2021)
Mixed steatohepatitis: more questions than answers (part 2)
Raikhelson K., Kondrashina E., Pazenko E.
PDF
(Rus)
卷 91, 编号 12 (2019)
Diabetes mellitus and chronic liver diseases. Literature review (part 2): treatment features
Kalmykova Z., Kononenko I., Mayorov A.
PDF
(Rus)
卷 91, 编号 10 (2019)
Diabetes mellitus and chronic liver diseases. Part 1: general mechanisms of etiology and pathogenesis
Kalmykova Z., Kononenko I., Mayorov A.
PDF
(Rus)
卷 93, 编号 8 (2021)
Obesity as a risk factor for diseases of the digestive system
Andreev D., Kucheryavyy Y.
PDF
(Rus)
卷 92, 编号 12 (2020)
Mixed steatohepatitis: more questions than answers (Part 1)
Raikhelson K., Kondrashina E., Pazenko E.
PDF
(Rus)
卷 88, 编号 2 (2016)
Evaluation of cardiovascular remodeling and epicardial fat thickness in patients with chronic heart failure and metabolic syndrome
Drapkina O., Zyatenkova E.
PDF
(Rus)
卷 93, 编号 8 (2021)
Diagnostic significance of clinical and laboratory indices in predicting non-alcoholic fatty liver disease during screening studies
Nosov A., Zenina M., Gorbushina O., Baidina A., Vlasova E., Alekseev V.
PDF
(Rus)
卷 91, 编号 2 (2019)
Comparative analysis of bile acid spectrum in non-alcoholic fatty liver disease and cholelithiasis
Vakhrushev Y., Lukashevich A., Penkina I., Suchkova E.
PDF
(Rus)
卷 89, 编号 1 (2017)
Involvement of the hepatobiliary system and pancreas in obesity
Akhmedov V., Gaus O.
PDF
(Rus)
卷 89, 编号 2 (2017)
Features of a necrotic and inflammatory process in different forms of nonalcoholic fatty liver disease
Kurbatova I., Dudanova O.
PDF
(Rus)
卷 91, 编号 4 (2019)
Biochemical and molecular-genetic indicators of inflammation and apoptosis in liver cirrhosis as an outcome of the progression of non-alcoholic steatohepatitis
Kurbatova I., Topchieva L., Dudanova O., Shipovskaya A.
PDF
(Rus)
卷 92, 编号 8 (2020)
Clinical features of the comorbid course of non-alcoholic fatty liver disease and gallstone disease
Cherkashchenko N., Livzan M., Krolevets T.
PDF
(Rus)
卷 92, 编号 2 (2020)
Features of the course of gallstone disease in patients with non-alcoholic fatty liver disease
Cherkashchenko N., Livzan M., Krolevets T.
PDF
(Rus)
卷 92, 编号 2 (2020)
Evaluation of the effectiveness of differentiated therapy of non-alcoholic fatty liver disease
Vakhrushev Y., Suchkova E., Lukashevich A.
PDF
(Rus)
卷 90, 编号 2 (2018)
Optimizing therapy of liver diseases not associated with viral infection
Svistunov A., Osadchuk M., Kireeva N., Osadchuk M.
PDF
(Rus)
卷 89, 编号 2 (2017)
Nonalcoholic fatty liver disease: What do we know and what will we have to learn?
Volkova N., Porksheyan M.
PDF
(Rus)
卷 86, 编号 10 (2014)
Current approaches to diagnosing and treating nonalcoholic fatty liver disease
Drapkina O., Deeva T., Volkova N., Ivashkin V.
卷 91, 编号 12 (2019)
Peculiarities of heart risk in patients with non - alcoholic fatial liver disease
Mosina L., Stolyarova V., Esina M., Titojkina Y., Korobkov D.
PDF
(Rus)
卷 89, 编号 2 (2017)
Clinical and metabolic features of nonalcoholic fatty liver disease in men and women
Krivosheev A., Kuimov A., Bogoryanova P., Kondratova M., Kupriyanova L., Popov K., Tuguleva T.
PDF
(Rus)
卷 86, 编号 10 (2014)
Adiponectin and parameters of glucose and lipid metabolism at different clinical and morphological stages of non-alcoholic fatty liver disease in patients with abdominal obesity
Komshilova K., Troshina E., Ershova E., Mazurina N., Platonova N.
卷 90, 编号 8 (2018)
The clinical significance of insulin resistance in non-diabetic patients with early forms of non-alcoholic fatty liver disease
Shipovskaya A., Dudanova O., Kurbatova I.
PDF
(Rus)
卷 88, 编号 12 (2016)
The informative value of non-invasive liver fibrosis markers in patients with nonalcoholic fatty liver disease
Livzan M., Akhmedov V., Krolevets T., Gaus O., Cherkaschenko N.
PDF
(Rus)
卷 84, 编号 6 (2012)
CLINICOPATHOGENETIC CHARACTERISTICS OF CARDIORENAL SYNDROME IN NON-ALCOHOLIC FATTY DISEASE OF THE LIVER
Severova M., Saginova E., Gallyamov M., Ermakov N., Rodina A., Fomin V., Mukhin N.
卷 89, 编号 12-2 (2017)
Nonalcoholic fatty liver disease without obesity: the problem to be solved
Bueverov A., Bogomolov P.
卷 88, 编号 9 (2016)
Nonalcoholic steatohepatitis and biliary sludge in people with metabolic syndrome
Radchenko V., Seliverstov P., Ledentsova S., Manyakov A.
PDF
(Rus)
卷 82, 编号 6 (2010)
Association of obstructive sleep apnea syndrome with the signs of non-alcoholic fatty liver disease and calculated glomerular filtration rate in metabolic syndrome
Severova M., Fomin V., Lebedeva M., Sorokin Y., Saginova E., Minakova E., Gallyamov M., Mukhin N.
卷 88, 编号 8 (2016)
Prevalence of nonalcoholic fatty liver disease in outpatients in Rostov-on-Don: Regional results of the DIREG-2 study
Tkachev A., Tarasova G., Groshilin V., Vasilchenkov D., Ushakova T., Blinov D.
PDF
(Rus)
1 - 39 的 39 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##